- XRP holders can now file a motion to intervene in the ongoing case between the Securities & Exchange Commission and Ripple Labs.
- According to Judge Analisa Torres's ruling, the motion to intervene must be filed no later than April 19.
- The SEC will then be able to file its opposition letters.
XRP holders are now claiming victory as attorney John Deaton has been allowed to file a motion to intervene in the ongoing case between the Securities & Exchange Commission (SEC) and Ripple Labs.
Permission to file a motion to intervene
According to the court order, Deaton was granted permission to file a motion to intervene in the case on behalf of XRP holders by Judge Analisa Torres. A motion to intervene must be filed no later than April 19, according to the ruling by Judge Torres. The SEC will then be able to file its opposition papers by May 3. The court order stated:
By May 17, 2021, the proposed intervenors shall file their reply to Plaintiff’s opposition papers and Defendants’ response papers, if any, and Plaintiff shall file a reply to Defendants’ response papers if any.
XRP holders previously claimed that their interests are not being adequately represented in the SEC's ongoing case against Ripple Labs and have sought to intervene with an initial filing. However, Deaton’s letter, initially representing 6,000 XRP holders to intervene in the lawsuit, was denied in mid-March.
Attorney Deaton did not give up and refiled the motion, representing 10,000 XRP holders the second time. An XRP holder himself, Deaton noted that the SEC’s action has resulted in the decline of the cryptocurrency’s value by over $15 billion.
The SEC urged the court on March 26 to prevent XRP holders from intervening in the case. The securities regulator put forward the argument that allowing XRP holders to intervene in the case would cause an “avalanche” of claims, as well as “complexity and confusion.”
Setting the record straight
The SEC’s vague claims against Ripple have rather ignited a remark made by one of the agency’s attorneys, indirectly indicating that cryptocurrency exchanges could relist XRP without violating any laws.
While urging the court to deny the motion to intervene, the SEC stated that reinstating “speculative trading” of XRP at crypto exchanges could play into Deaton’s intention of doubling the price of the digital asset. The regulatory agency cited a previous FXStreet article, saying:
As Movant Deaton has stated elsewhere, the purpose of re-listing appears to be so that XRP’s price could double.
Stating that he does not talk about the XRP price, Deaton clarified that SEC attorney Tenreiro is “clearly trying to make me look bad by claiming that my motivation in seeking to intervene is for profit-taking.”
Deaton only commented on the likelihood of whether the SEC would give the green light for exchanges to relist XRP, especially since its price could double, enabling Ripple Labs to have twice the money to go forward with the case.
The SEC’s letter to Judge Torres objecting to the motion to intervene is one of the most misleading letters he has ever read, he added.
Attorney Deaton plans to dispute the SEC’s argument that XRP does not have any utility by gathering businesses, developers and entities that use XRP operationally.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.